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Abstract Calcium and phosphate regulate parathyroid hor-
mone (PTH) mRNA stability through di¡erences in binding of
parathyroid proteins to an element in its 3P-untranslated region.
One of the proteins is AUF1 (A+U-rich element binding factor
1). An in vitro degradation assay showed that transcripts for
PTH and chimeric growth hormone (GH)^PTH 63 nt, but not
for native GH, were stabilized by PT proteins from rats on low
calcium diets and destabilized by proteins from rats on low
phosphate diets, correlating with PTH mRNA levels in vivo.
In transfection experiments the 63 nt binding element destabi-
lized mRNAs of reporter genes and this was prevented by over-
expression of AUF1. Our results identi¢ed a functional cis ele-
ment in PTH mRNA. Di¡erences in protein binding to this
element determine PTH mRNA stability and its regulation by
calcium and phosphate. 1 2002 Published by Elsevier Science
B.V. on behalf of the Federation of European Biochemical So-
cieties.
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1. Introduction
Parathyroid hormone (PTH) has a central role in maintain-
ing normal calcium (Ca2þ) and phosphate (Pi) homeostasis as
well as bone strength. Dietary induced hypocalcemia mark-
edly increases PTH mRNA levels, secretion and after pro-
longed stimulation, parathyroid (PT) cell proliferation [1]. A
seven trans-membrane G coupled Ca2þ sensing receptor on
the PT cell membrane senses changes in extracellular Ca2þ
concentrations [2]. How low Ca2þ regulates the levels of
PTH secretion, gene expression and PT cell proliferation is
still not clear. We have shown that the increase in PTH
mRNA levels is post-transcriptional [3]. Pi also regulates
PTH secretion, gene expression and PT cell proliferation [4].
Dietary induced Pi depletion dramatically decreases PTH
mRNA levels and this is also post-transcriptional [5]. There
is aV60-fold di¡erence in PTH mRNA levels between hypo-
calcemic and hypophosphatemic rats and we used these die-
tary models as tools to de¢ne the mechanism of the post-tran-
scriptional regulation of PTH gene expression. We have
shown that the post-transcriptional regulation by dietary in-
duced hypocalcemia and hypophosphatemia is mediated by
protein^RNA interactions involving protein binding to a spe-
ci¢c element in the PTH mRNA 3P-untranslated region
(UTR) that determine PTH mRNA stability [3]. We suggest
that after a low Ca2þ diet there is increased binding to the
PTH mRNA 3P-UTR that protects the RNA from degrada-
tion resulting in increased PTH mRNA levels. After a low Pi
diet there is less binding that allows more degradation and
leads to the decrease in PTH mRNA levels (Fig. 1).
2. Protein binding regulates PTH mRNA stability
Weanling rats were fed a control diet or diets de¢cient in
Ca2þ (low calcium) or Pi (low Pi) for 2 weeks. A low Ca2þ
diet resulted in a 10-fold increase in PTH mRNA levels and a
low Pi diet to a six-fold decrease compared to the rats fed a
control diet. Protein binding to the PTH mRNA 3P-UTR was
increased by hypocalcemia and decreased by hypophosphate-
mia by RNA electrophoretic mobility shift assay (REMSA)
and UV cross-linking gels, in correlation with PTH mRNA
levels (Fig. 1). This binding was regulated by Ca2þ and Pi
only in the PT and not in other tissues. UV cross-linking of
PT proteins to transcripts for the full-length and the 3P-UTR
showed three protein^RNA bands. To identify the PTH
mRNA-binding proteins we have performed PTH RNA 3P-
UTR a⁄nity chromatography. One of the puri¢ed proteins
was sequenced and was identical to A+U-rich element binding
factor 1 (AUF1) protein (hnRNP D) [6] which is known to be
important to the stability of other mRNAs [7]. Recombinant
AUF1 bound the PTH mRNA 3P-UTR with a single band at
50 kDa, which corresponds to one of three protein^RNA
bands found with cytosolic PT proteins by UV cross-linking
gels. Brewer et al. have cloned this RNA-binding protein
which binds with high a⁄nity to a variety of A+U-rich ele-
ments (AREs) in the 3P-UTRs of a number of mRNAs [8].
These include mRNAs for cytokines, oncoproteins, and G
protein coupled receptors, where AUF1 is involved in the
degradation of these mRNAs [9]. Three classes of AREs
have been characterized, two of which contain several scat-
tered or overlapping copies of the pentanucleotide AUUUA
[10], [11]. The class III AREs lack the AUUUA motif but
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require a U-rich sequence and possibly other unknown deter-
minants [10]. It has been shown that the AUUUA motif is not
required for AUF1 binding [12]. The PTH mRNA 3P-UTRs
are rich in A and U ranging from 68 to 74% of the nucleotides
[13]. The PTH mRNA 3P-UTR-binding element (see below) is
a type III ARE that does not contain any AUUUA sequences
[14]. There are four isoforms for AUF1 that are generated by
alternative splicing of the AUF1 transcript [15]. The activity
of AUF1 may be determined by the presence of other proteins
in the binding complex, such as KCP1 and 2 in stabilizing the
K-globin mRNA [16]. Two additional PTH mRNA-binding
proteins were identi¢ed by the a⁄nity chromatography (not
shown) as hnRNP K [17,18] and up stream of nRAS (UNR)
[19]. These proteins were shown to bind PTH transcripts by
binding assays using recombinant proteins. Speci¢c antibodies
to each of the three identi¢ed proteins led to a super shift in
the binding of PT proteins to the PTH mRNA 3P-UTR, dem-
onstrating that they are part of the protein^RNA complex
(not shown).
There is no PT cell line therefore we have utilized a cell-free
mRNA in vitro degradation assay (IVDA) to demonstrate the
functionality of the PT cytosolic proteins in determining the
stability of the PTH transcript. This assay has been shown to
authentically reproduce cellular decay processes [20]. PT pro-
teins from control rats incubated with a full-length PTH
mRNA probe led to gradual degradation of the PTH tran-
script, which was a result of degrading and protective factors
present in the cytosolic extract. The transcript was intact until
40 min with PT proteins from control rats. However, with
hypocalcemic PT proteins the transcript was not degraded
until 180 min and with hypophosphatemic proteins only until
5 min, correlating with mRNA levels in vivo (Figs. 2A and 3B
upper gel) [3]. Therefore, the IVDA reproduces the in vivo
stabilizing e¡ect of low Ca2þ and destabilizing e¡ects of low
Pi on PTH mRNA levels. A transcript that did not include the
3P-UTR or just the 60 nt terminal protein-binding region of
the PTH mRNA 3P-UTR was more stable than the full-length
PTH transcript and was intact for more than 180 min (Fig.
2B). This suggests that the binding region is an instability
element. Moreover, Ca2þ (not shown) and Pi (Fig. 2B) did
not regulate the stability of the truncated transcript that did
not include the protein-binding region [3]. Therefore, the reg-
ulation by PT proteins from low Ca2þ and Pi rats in the
IVDA is dependent upon the protein-binding sequence in
the PTH mRNA 3P-UTR.
To study the e¡ect of AUF1 on PTH RNA degradation,
recombinant AUF1 was added to the IVDA. Addition of
recombinant AUF1 p37 and p40 isoforms stabilized the
PTH transcript even by hypophosphatemic proteins, that
without AUF1 led to rapid degradation of the full-length
PTH transcript [6]. Other control proteins, bovine serum al-
bumin and dynein light chain (Mr 8000) (LC8) [21], which we
have shown also binds to the PTH mRNA 3P-UTR, had no
e¡ect [22]. This result supports the regulatory role of AUF1 in
PTH mRNA stability. The role of the other two PTH mRNA-
binding proteins that we have identi¢ed, hnRNP K and UNR,
in this regulation still remains to be determined.
3. Identi¢cation of the minimal protein-binding element in the
PTH mRNA 3P-UTR and demonstrating its functionality
Binding and competition experiments by REMSA and UV
cross-linking gels identi¢ed a minimal sequence of 26 nt that
was su⁄cient for PT protein binding [14]. Sequence analysis
of the 26 nt element in the PTH mRNA revealed high con-
servation of the rat element in the PTH mRNA 3P-UTRs of
the murine (23 of 26 nt), human (19 of 26 nt) and canine (19
of 26 nt) species, with human and canine being identical. Such
conservation of this sequence that lies outside of the coding
region, amongst di¡erent species, suggests a functional role
for this element.
To study the functionality of the protein-binding element in
Fig. 1. Regulation of PTH mRNA stability involves PT protective and degrading proteins. Schematic representation of the PTH mRNA with
the protective RNA-binding proteins (square) and the degrading ribonucleases that degrade the RNA (packman). Protein binding is increased
after a low Ca2þ diet resulting in protection of the bound RNA and an increase in PTH mRNA. After a low Pi diet there is less binding,
more degradation and a decrease in PTH mRNA levels. The PTH mRNA-binding proteins, AUF1, hnRNP K and UNR are shown and the
conserved 26 nt element is indicated.
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the context of another RNA, a 63 bp fragment encoding the
26 nt of the PTH mRNA 3P-UTR and £anking nt, was fused
to growth hormone (GH) reporter gene (Fig. 3A). RNAs were
transcribed in vitro and transcripts subjected to IVDA with
PT proteins. The chimeric GH^PTH 63 nt transcript, as the
full-length PTH transcript, was stabilized by PT proteins from
rats fed a low Ca2þ diet and destabilized by PT proteins of a
low Pi diet, correlating with PTH mRNA levels in vivo. The
native GH transcript was more stable than PTH and the chi-
meric RNAs and was not a¡ected by PT proteins from the
di¡erent diet (Fig. 3B). Therefore, the PTH RNA^protein-
binding region destabilized the GH transcript in the presence
of PT proteins. Furthermore, this element conferred respon-
siveness of GH to changes in PT proteins by Ca2þ and Pi [14].
The results demonstrate that the protein-binding region of the
PTH mRNA 3P-UTR is both necessary and su⁄cient for de-
termining RNA stability and for the response to Ca2þ and Pi.
We then studied the function of the PTH element in cells,
using the heterologous cell line HEK293. cDNAs encoding
the protein-binding region of the PTH mRNA 3P-UTR were
inserted at the 3P-end of two reporter cDNAs. 63 bp of the
PTH 3P-UTR were inserted into a GFP construct driven by a
CMV promoter and a larger fragment of 100 bp into a GH
construct driven by a S16 promoter. The plasmids were tran-
siently transfected into HEK293 cells. At 24 h mRNA levels
were measured by Northern blot, and protein levels of GFP
by immuno£uorescence, and secreted GH by radioimmuno-
assay. There was a dramatic reduction in the expression of the
chimeric genes containing the PTH elements compared to the
wild type genes. A truncated PTH 40 nt element had no e¡ect
on reporter gene expression (not shown). The 100 and 63 nt
transcripts, like the full-length PTH RNA, bound PT proteins
by UV and REMSA, but the truncated element did not bind
PT proteins. The di¡erent constructs for each reporter gene all
used the same promoter, therefore these results suggest that
insertion of the PTH 3P-UTR element decreased the stability
of the reporter transcripts and not their transcription levels.
Inhibition of transcription by the addition of DRB to the
transfected cells and the measurement of mRNA decay con-
¢rmed that the decrease in mRNA levels was post-transcrip-
tional (not shown). These results are in agreement with the
decreased stability of the GH chimeric transcript in the IVDA
with PT proteins (Fig. 3B). They are consistent with the de-
stabilizing e¡ect of the cis element in the PTH mRNA.
Over-expression of AUF1 by cotransfection of the reporter
genes together with expression plasmids for myc-tagged
AUF1 isoforms [23] prevented the rapid degradation of the
chimeric mRNAs containing the PTH element (not shown).
This was observed with all the myc-tagged isoforms (not
shown). Western blots con¢rmed the expression of the myc-
AUF1 proteins in the cells. These results suggest that the
destabilizing a¡ect of the PTH element is due to insu⁄cient
amount of AUF1 in the transfected cells and that this is
reversed in the presence of increased levels of AUF1. AUF1
therefore inactivates the rapid RNA decay directed by the
PTH mRNA 3P-UTR-binding element.
The mechanism of the stabilizing e¡ect of AUF1 is not
clear. In the PT low Ca2þ and Pi do not elevate the level of
AUF1 by Western blots. Preliminary results show di¡erences
in post-translational modi¢cations, possibly phosphorylation
rather than the amount of AUF1 protein. Recent studies
show alterations in RNA^protein binding and RNA stability
in response to speci¢c signal transduction pathways. One
study showed that activation of p38 mitogen activated protein
kinase induced by proin£amatory cytokines inhibited mRNA
decay [24]. It is possible that in vivo PTH mRNA turnover is
controlled by phosphorylation^dephosphorylation by speci¢c
Fig. 2. In vitro degradation of PTH RNA by PT cytosolic proteins
is regulated by Ca2þ and Pi and dependent on the 60 nt terminal of
the PTH mRNA. A: Time^response curve for IVDAs of the full-
length PTH transcript incubated with PT proteins from rats fed a
normal, low Ca2þ (^Ca) or low Pi (^P) diet. Each point represents
the meanQS.E.M. of three or four di¡erent experiments, apart
from ^Ca at 240 and 300 min which is the mean of two experi-
ments. At some points the S.E.M. is less than the size of the
graphic symbols. The PTH transcript was stabilized by PT proteins
from ^Ca rats and rapidly degraded by proteins from ^P rats. B:
Mapping a region in the PTH 3P-UTR that mediates degradation
by PT proteins from ^P rats. Time^response curve of the IVDA
with transcripts for the full-length and shorter PTH mRNA tran-
scripts incubated with PT proteins from low Pi rats. PTH mRNA
probes used are intact (full-length), without the 3P-UTR, and with-
out the 3P-terminal 60 nt of the 3P-UTR. The PTH transcript that
did not contain the protein-binding region was not degraded by PT
proteins.
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kinases and phosphatases that are responsible for the direct
modi¢cations. In the experimental models of the IVDA and
transfection experiments excess AUF1 compensates for mod-
i¢cations that may occur in vivo and are absent in vitro.
4. The structure of the PTH cis acting element
The IVDA and the transfection experiments demonstrate
the functional importance of the RNA^protein-binding region
in the PTH 3P-UTR. RNA utilizes sequence and structure for
its regulatory functions. We have studied the structure of the
PTH mRNA 3P-UTR in order to understand the mechanism
by which it regulates mRNA half-life both in vitro and in
vivo. Using primer extension experiments, RNase H analysis
and computer structure modeling we have shown that the 100
nt that include the 26 nt protein-binding core and £anking
sequences have a de¢ned loop^stem^loop structure (not
shown). This structure is maintained when the full-length
transcript is studied. Mutation analysis con¢rm that this
structure is important for protein binding and for the desta-
bilizing e¡ect of the cis acting element in transfection experi-
ments with GFP as a reporter gene.
5. Conclusion
Dietary induced hypocalcemia and hypophosphatemia reg-
ulate PTH gene expression post-transcriptionally and this is
dependent upon the binding of PT cytosolic proteins to insta-
bility regions in the PTH mRNA 3P-UTR. The binding of
these cytosolic proteins to the PTH mRNA is increased in
hypocalcemia and decreased in hypophosphatemia correlating
with PTH mRNA levels in vivo. There is no PT cell line and
the stability of PTH transcripts was studied by an IVDA. PT
proteins from hypocalcemic rats lead to an increase in PTH
RNA stability in the IVDA and hypophosphatemic proteins
to a marked decrease in stability. One of the PTH mRNA-
binding proteins is AUF1 that stabilizes the PTH mRNA. We
have identi¢ed a conserved 26 nt element in the PTH mRNA
3P-UTR as the minimal protein-binding sequence. The func-
tionality of a 63 nt element that included the 26 nt was studied
in reporter RNAs. The stability of the chimeric RNAs was
studied in the IVDA with PT proteins of low Ca and Pi rats
and in transfection experiments in HEK 293 cells. This ele-
ment destabilized the reporter genes and was su⁄cient to con-
fer responsiveness to Ca2þ and Pi in the IVDA. Our results
demonstrated a functional cis element in the PTH mRNA 3P-
UTR. Di¡erences in binding of trans acting factors to this
element determine PTH mRNA stability and its regulation
by Ca2þ and Pi. The understanding of the mechanism of
how Ca2þ and Pi regulate PTH gene expression will allow
the design of novel treatment strategies for diseases such as
the secondary hyperparathyroidism of chronic renal failure.
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Fig. 3. The PTH mRNA 3P-UTR 63 nt protein-binding region confers responsiveness of GH mRNA to PT proteins from rats fed low Ca2þ or
low Pi diets in an IVDA. A: Schematic representation of the PTH mRNA (above), GH mRNA and the chimeric GH mRNA containing the
PTH 3P-UTR 63 nt element inserted at the end of the GH coding region (bottom). B: Representative gels of IVDAs for labeled transcripts for
PTH (top), GH (middle) and GH+63 nt of the PTH 3P-UTR (bottom) with PT proteins from rats fed a normal, low Ca2þ or low Pi diet. At
timed intervals after protein and RNA incubation samples were removed for RNA analysis. The chimeric GH transcript was less stable than
the native GH. The full-length PTH and the chimeric GH^PTH 63 transcripts were stabilized with low Ca2þ PT proteins and destabilization
with low Pi PT proteins. The PT proteins from the di¡erent diets had no a¡ect on the native GH transcript.
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